Showing results (31-40 of 138) with videos related to

Sort By:
Pageof 14
International Journal of Cancer|March 4, 2000
Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase AF Ciardiello, R Caputo, G Pomatico, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growthG Tortora, R Caputo, G Pomatico, et al.
British Journal of Cancer|May 1, 1991
Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancerA R Bianco, L Del Mastro, C Gallo, et al.
International Journal of Cancer|November 10, 2000
A novel MDM2 anti-sense oligonucleotide has anti-tumor activity and potentiates cytotoxic drugs acting by different mechanisms in human colon cancerG Tortora, R Caputo, V Damiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1997
8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancerC Bianco, G Tortora, G Baldassarre, et al.
Hematological Oncology|July 1, 1990
Salvage chemotherapy for non Hodgkin's lymphoma of unfavourable histology with a combination of CCNU and vinblastineG Palmieri, R Lauria, F Caponigro, et al.
Thymus|January 1, 1988
Effect of thymic extract 'thymostimulin' on the incidence of infections and myelotoxicity during adjuvant chemotherapy for breast cancerR V Iaffaioli, G Frasci, G Tortora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitorF Ciardiello, R Caputo, R Bianco, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancerC Gridelli, S De Placido, R Pepe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Phase I study of ifosfamide plus high-dose epirubicin in advanced non-small-cell lung cancerC Gridelli, A Rossi, P Incoronato, et al.
Pageof 14